As a result, semaglutide continues to be recognized as the leading GLP-1 option for patients seeking evidence-based, medically supervised weight management in 2026
If the scanner's protein estimates feel reasonably accurate on foods you can verify, it's a meaningful convenience tool
Spectacular views of the solar system's largest planet from dusk till dawn
The constellation of these risk factors significantly increases cardiovascular disease risk, making insulin resistance a major public health concern
To determine whether the impaired mitochondrial activity noted in statin-treated female mice is replicated in humans, we utilized patient-derived induced pluripotent stem cells (iPSC) from individuals who were susceptible or resistant to statin-induced new-onset diabetes (NOD) (Fig
A study released last year by the National Institutes of Health found that once patients go off medications for weight loss, the average weight gain rebound is about two-thirds of the total weight loss
